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In the present work human Ribonuclease 7, a prominent member of the 
pancreatic ribonuclease A superfamily was produced by heterologous expression in 
E. coli, purified by chromatography and characterized by determining its enzymatic 
activity with zymography.  The enzyme was expressed in E. coli BL21 cells, 
transformed with the pET11c vector that had an insertion of a synthetic gene 
encoding Ribonuclease 7.  Ribonuclease 7 was purified from inclusion bodies using a 
denaturation/refolding protocol and cation exchange chromatography using a DEAE 
– sepharose and a CM – sepharose column. Purity of the isolated protein was 
evaluated using SDS page electrophoresis, and quantification by the Beer-Lambert 
principle. Ribonuclease activity of the purified protein was determined using poly(U) 
as a substrate by SDS electrophoresis.  Evaluation of the antimicrobial activity was 
performed by counting colonies in agar plates after incubating bacteria with the 
proteins. Finally, attempts for crystallization of the Ribonuclease 7 were performed 
using the method of the hanging drop. 
 
Περίληψη  
Στην παρούσα εργασία, η ανθρώπινη ριβονουκλεάση 7, ένα διακεκριμένο 
μέλος της παγκρεατικής υπεροικογένειας της ριβονουκλεάσης Α, παράχθηκε με 
ετερόλογη έκφραση σε Ε. coli, καθαρίστηκε με χρωματογραφικές μεθόδους και 
χαρακτηρίστηκε με προσδιορισμό της ενζυματικής της δράσης με ζυμογραφία. Το 
ένζυμο εκφράστηκε στα βακτηριακά στελέχη της Ε. coli BL21, τα οποία 
μετασχηματίσθηκαν με το φορέα pET11c που περιέχει μια ένθεση ενός συνθετικού 
γονιδίου που κωδικοποιεί τη ριβονουκλεάση 7. Η ριβονουκλεάση καθαρίστηκε από 
έγκλειστα σωμάτια χρησιμοποιώντας ένα πρωτόκολλο μετουσίωσης/αναδίπλωσης 
και χρωματογραφία κατιονικής ανταλλαγής, χρησιμοποιώντας μια στήλη DEAE – 
σεφαρόζης και μία στήλη CM – σεφαρόζης. Η καθαρότητα της απομονωμένης 
πρωτεΐνης εκτιμήθηκε χρησιμοποιώντας ηλεκτροφόρηση SDS – PAGE και η 
ποσότητα της υπολογίστηκε με τη μέθοδο Beer-Lambert. Η ενζυμική δραστικότητα 
της καθαρής πρωτεΐνης προσδιορίστηκε χρησιμοποιώντας ως υπόστρωμα πολύ(U) 
σε ηλεκτροφόρηση SDS και η εκτίμηση της αντιμικροβιακής της δράσης έγινε 
μετρώντας τις αποικίες βακτηρίων που σχηματίστηκαν σε τρυβλία άγαρ, μετά από 
επώαση των πρωτεϊνών με τα βακτήρια. Τέλος, καταβλήθηκαν προσπάθειες για 




Institutional Repository - Library & Information Centre - University of Thessaly


























Institutional Repository - Library & Information Centre - University of Thessaly






Ribonuclease, which is commonly abbreviated as RNase, is a type of 
nuclease that catalyzes the degradation of RNA into smaller components. 
Ribonucleases can be divided into endoribonucleases and exoribonucleases and 
comprise several sub-classes.  
 
1.2 Function 
All organisms studied contain many RNases of many different classes, 
showing that RNA degradation is a very ancient and important process. As well as 
cleaning of cellular RNA that is no longer required, so that cells do not become 
cluttered with waste, RNases play key roles in the maturation of all RNA molecules, 
both messenger RNAs that carry genetic material for making proteins, and non-
coding RNAs that function in varied cellular processes. In addition, active RNA 
degradation systems are a first defense against RNA viruses, and provide the 
underlying machinery for more advanced cellular immune strategies such as RNAi. 
RNASE genes are active in many cells and tissues, including different immune system cells. 
The variety of tissue activity likely supports the ability of RNase enzymes to help fight 
infection throughout the body.  
Some cells also secrete copious quantities of non-specific RNases such as A 
and T1. RNases are, therefore, extremely common, resulting in very short lifespans 
for any RNA that is not in a protected environment. It is worth noting that all 
intracellular RNAs are protected from Rnase activity by a number of strategies 
including 5’ end capping, 3’ end polyadenylation, and folding within an RNA protein 
complex (ribonucloprotein particle or RNP).  
RNases play a critical role in many biological processes, including angiogenesis 
and self-incompatibility in flowering plants (angiosperms). Also, RNases in 
prokaryotic toxin-antitoxin systems are proposed to function as plasmid stability loci, 
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2. Genes in the RNASE family 
The HUGO Gene Nomenclature Committee (HGNC) provides a list of genes in 















ribonuclease, RNase A family, 2 (liver, 
eosinophil-derived neurotoxin) 
RNS2 EDN 14q24-q31 
RNASE3  ribonuclease, RNase A family, 3 RNS3 ECP 14q24-q31 




angiogenin, ribonuclease, RNase A 




RNASE6  ribonuclease, RNase A family, k6 RNS6 
 
14q11 
RNASE7  ribonuclease, RNase A family, 7 
  
14q11.1 


















ribonuclease, RNase A family, 12 (non-
active)   
14q11.1 
RNASE13  
ribonuclease, RNase A family, 13 (non-
active)   
14q11.1 
Table 1. Genes in the RNASE family. 
 
Proteins encoded by members of the RNASE gene family all share a similar 
structure and enzyme activity. All the genes in the RNASE gene family are found on 
chromosome 14. Thirteen genes have been identified in the RNASE gene family, but 
only eight of the genes in this family are designated by the letters RNASE followed by 
a unique number identifier, starting with the number one. For example, the first 
identified member of this gene family is the gene RNASE1. 
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3. Ribonuclease A (RNase A)  
Ribonuclease A (RNase A) is a pancreatic endoribonucleases that cleaves 
single-stranded RNA. Bovine pancreatic RNase A is one of the classic model systems 
of protein science.  
 
3.1 History 
The importance of bovine pancreatic RNase A was secured when the Armour 
& Co purified a kilogram of it, and gave 10 mg samples away free to any interested 
scientists. The ability to have a single lot of purified enzyme instantly made RNase A 
a predominant model system for protein studies. 
RNase A was the model protein used to work out many spectroscopic 
methods for assaying protein structure, including absorbance, circular 
dichroism/optical rotary dispersion, Raman, EPR and NMR spectroscopy. RNase A 
was also the first model protein for the development of several chemical and 
structural methods, such as limited proteolysis of disordered segments, chemical 
modification of exposed side chains, and antigenic recognition. 
RNase A was the first enzyme for which a correct catalytic mechanism was 
proposed, even before its structure was known. RNase A was also the first protein 
showing the effects of non-native isomers of X-Pro peptide bonds in protein folding. 
RNase A was the first protein to be studied by multiple sequence alignment and by 
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RNase A is a relatively small protein (~13.7 kDa), the mature enzyme has 124 
amino acid residues, with no carbohydrate attached. RNase A contains 19 of the 20 
amino acids, lacking only tryptophan .The RNase A superfamily has been the subject 
of intense biochemical study for over half a century. The prototype, RNase A (bovine 
pancreatic ribonuclease) was the first enzyme to be sequenced and chemically 
synthesized, and the classic experiments on the denaturation and renaturation of 
this protein appear in virtually every biochemistry textbook. During the past two 
decades, dozens of novel ribonucleases of this superfamily have been identified in 
multiple vertebrate species. As a group, all RNase A superfamily members are 
secretory proteins, and include a classic hydrophobic signal peptide followed by a 
mature peptide with molecular mass of ∼12–16 kDa in unglycosylated state. All 
RNase A ribonucleases maintain three specific catalytic residues—one lysine and two 
histidines—that comprise a catalytic crevice, and six to eight appropriately‐spaced 
cysteines that form three to four disulfide bonds. Except for these conserved 
residues, the RNases are otherwise quite divergent, with sequence identities varying 
from 30 to nearly 100%. Although all RNase A ribonucleases are enzymatically active, 
catalytic efficiency and substrate preference vary considerably.  
 
Figure 1. RNase A: The backbone ribbon is colored from blue (N-terminus) to red (C-
terminus). The side chains of the four disulfide-bonded cysteines are shown in 
yellow, with their sulfur atoms highlighted as small spheres. Residues important for 
catalysis are shown in magenta. 
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RNase A is a basic protein (pI = 9.63); its many positive charges are consistent 
with its binding to RNA (a poly-anion). More generally, RNase A is unusually polar or, 
rather, unusually lacking in hydrophobic groups, especially aliphatic ones. This may 
account for its need of four disulfide bonds to stabilize its structure. The low 
hydrophobic content may also serve to reduce the physical repulsion between highly 
charged groups (its own and those of its substrate RNA) and regions of low dielectric 
constant (the nonpolar residues). 
 
3.3 RNase A specificity  
RNase A is specific for pyrimidine nucleoside linkages. The reaction is 
believed to take place in two steps. In the first step, the 3’,5’-phosphodiester bond is 
cleaved, while generating a 2’,3’-cyclic phosphodiester intermediate. In the second 
step, the cyclic phosphodiester is hydrolyzed to a 3’-monophosphate group. The first 
step is nonspecific with respect to the nitrogenous base of the substrate; however, 
the second step is absolutely specific for pyrimidine nucleotides with terminal 2’,3’-
cyclic phosphates. It can be inhibited by ribonuclease inhibitor protein, by heavy 
metal ions, and by uridine-vanadate complexes and it can be activated by Sodium 
chloride and Sulfate.  
 
 
Figure 2. RNase A catalysis 
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3.4 Anti-cancer effects 
RNase A, and to a greater extent its oligomers and some homologs (such 
as onconase from frogs), have cytotoxic and cytostatic effects, particularly on cancer 
cells. This attribute has led to the development of onconase as a cancer therapeutic. 
As with many protein drugs from a non-human source, the internal use of non-
human ribonucleases such as onconase is limited by the patient's immune response 
Antitumor ribonucleases are small (10–28 kDa) basic proteins. They were 
found among members of both, ribonuclease A and T1 superfamilies. Their cytotoxic 
properties are conferred by enzymatic activity, i.e., the ability to catalyze cleavages 
of phosphodiester bonds in RNA. They bind to negatively charged cell membrane, 
enter cells by endocytosis and translocate to cytosol where they evade mammalian 
protein ribonuclease inhibitor and degrade RNA.  
Onconase, is the only enzyme of cytotoxic ribonucleases this class that 
reached clinical trials. Onconase is the smallest, very stable, less catalytically efficient 
and more cytotoxic than most RNase A homologues. Its cytostatic, cytotoxic and 
anticancer effects were extensively studied. It targets tRNA, rRNA, mRNA as well as 
the non-coding RNA (microRNAs). Numerous cancer lines are sensitive to Onconase; 
their treatment with 10 – 100 nM enzyme leads to suppression of cell cycle 
progression, predominantly through G1, followed by apoptosis or cell senescence. 
Onconase also has anticancer properties in animal models. Many effects of this 
enzyme are consistent with the microRNAs, one of its critical targets. Onconase 
sensitizes cells to a variety of anticancer modalities and this property is of particular 
interest, suggesting its application as an adjunct to chemotherapy or radiotherapy in 
treatment of different tumors. Cytotoxic RNases as exemplified by Onconase 
represent a new class of antitumor agents, with an entirely different mechanism of 
action than the drugs currently used in the clinic. Further studies on animal models 
including human tumors grafted on severe combined immunodefficient (SCID) mice 
and clinical trials are needed to explore clinical potential of cytotoxic RNases. 
 
 
Figure 3. 3-D structure of onconase 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 10:16:14 EET - 137.108.70.7
15 
 
4. RNase 7 
RNase 7 belongs in the RNase A superfamily of ribonucleases identified in the 
human genome sequence. Members of this family, as it has been already mentioned, 
share a conserved structure of six or eight cysteines linked by disulfide bonds and 
two histidines and one lysine that form the catalytic site. RNase 7 is fairly typical for 
a member of the RNase A family. Its open reading frame encodes a 28-amino acid 
signal sequence and the mature protein sequence includes 8 cysteines and 
appropriately localized histidines and lysines, the latter within the family signature 
motif. The human RNase 7 gene is expressed in various somatic tissues including the 
liver, kidney, skeletal muscle and heart and in various epithelial tissues including 
skin, respiratory tract, genito-urinary tract and, at a low level, in the gut.  
RNase 7 is an intriguing secretary and cationic ribonuclease with a calculated 
isoelectric point (pI) of 9,8 and has unique structure and  antimicrobial activity, 
particularly powerful against several pathogenic microorganisms, both Gram 
negative and Gram positive.  
 
4.1 RNase 7 as an AMP 
Antimicrobial peptides (AMPs), a fundamental component of the innate 
immune system, are small cationic molecules expressed by phagocytic white cells 
and epithelial cells. AMPs typically have broad-spectrum antimicrobial activity 
against Gram-positive bacteria, Gram-negative bacteria, enveloped viruses, fungi, 
and some protozoa. 
 Ribonuclease 7 (RNase 7) is a potent AMP that was first identified in the skin, 
while searching for antimicrobial proteins of human skin, during screening the 
human genome. Molecular cloning from skin-derived primary keratinocytes and 
purification of RNase 7 from supernatants of cultured primary keratinocytes indicate 
that keratinocytes represent the major cellular source in skin and that RNase 7 is 
secreted. It is also demonstrated that RNase 7 protects healthy skin against infection 
and colonization, respectively with Staphylococcus aureus. RNase 7 is expressed 
widely and is induced in keratinocyte culture by prominent proinflammatory stimuli 
including TNF, IFNγ, IL-1β and IL-1α, as well as UV-irradiation and bacterial 
components. 
Currently, the mechanisms for RNase 7’s antimicrobial properties are not 
completely understood. Its bactericidal activity has been linked to its capacity to 
permeate and disrupt the bacterial cell membrane, independent of its ribonuclease 
activity. As it is already mentioned, RNase 7, like many human AMPs, is highly 
cationic protein and clusters of flexible cationic lysine residues on the surface of 
RNase 7 are thought to be critical for its antimicrobial activity. It is supposed that 
RNase 7 binds to negatively-charged bacterial membranes through these cationic 
residues. Upon binding to the bacterial membrane, RNase 7 incorporates itself 
within the membrane, disrupting its physical and functional characteristics, killing 
the microbe. The toxicity of RNase 7 is directed mainly towards bacteria, as studies 
show that it is not cytotoxic to human uroepithelial cells, red blood cells and human 
keratinocytes. 
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4.2 RNase 7 in the urinary tract 
 Rnase7 is a potent epithelial-derived AMP that plays a crucial role in the 
urinary tract, which is constantly challenged by microbial invasion, but remains free 
from colonization. Although little is known about how the urinary tract maintains 
sterility, the presence of antimicrobial peptides (AMPs) in the urine suggests that 
they may play a role in its protection from infection. Ribonuclease 7 (RNase 7) is a 
potent AMP. As far as the expression and relevance of RNase 7 in the human kidney 
and urinary tract are concerned, basal RNase 7 expression in kidney and bladder 
tissue was found by using RNA isolated from healthy human tissue and performing 
quantitative real-time PCR. Immunohistochemical and immunofluorescent analysis 
localized RNase 7 to the urothelium of the bladder, ureter, and the intercalated cells 
of the collecting tubules. RNase 7 is present in the urine at levels sufficient to kill 
bacteria. It has been stated that, on a per molar basis, RNase 7 is the most potent 
human AMP. Antibacterial neutralization assays showed that urinary RNase 7 has 
potent antimicrobial properties against Gram-negative and Gram-positive 
uropathogenic bacteria.  
Thus, RNase 7 is expressed in the human kidney and urinary tract and it may 
have an important antimicrobial role in maintaining tract sterility, as it is shown by 
quantitative real-time PCR analysis, which demonstrates that RNase 7 expression 
increases with acute pyelonephritis. These results suggest that RNase 7 may be an 
important AMP for the defense and prevention of early infection in the upper 
urinary tract. However, at chronic pyelonephritis and other chronic bacterial 
infections, there is a lack of RNase7 induction, supporting the notion that RNase 7 
may be critical to mounting an innate immune response that favors rapid microbial 
clearance. Thus, RNase 7 may be more important during early states of infection 
than in later stages of disease. The observed decrease in RNase 7 expression with 
chronic infection may represent a pathogenic mechanism aimed at overwhelming 
the innate immune response, inhibiting RNase 7 synthesis, and allowing pathogens 
to evade innate defenses to cause disease.  
 
4.3 RNase 7 in cutaneous defense 
  The role of RNase 7 in cutaneous defense is important, as well. A detailed 
analysis of its in vitro as well as in vivo expression together with functional 
antimicrobial studies suggest that RNase 7 may play a major role in skin defense and 
contributes to the high resistance of human skin against colonization with the gram-
positive gut bacterium E. faecium.  
The recent isolation of the antimicrobial ribonuclease RNase 7 from stratum 
corneum of healthy skin revealed its critical role in cutaneous defense. A quantitative 
analysis revealed that primary keratinocytes express high levels of RNase 7 mRNA 
when compared to other skin-derived antimicrobial proteins such as psoriasin, hBD-
2, and LL-37. This observation further strengthened the hypothesis that RNase 7 may 
be an important defense molecule in cutaneous innate immunity. 
Immunohistochemistry using RNase 7 specific antibodies revealed expression of 
RNase 7 in all layers of human epidermis with higher intensity in the more outer 
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differentiated epithelial layers. Hair follicles also stained positively which is in 
concordance with a recent study demonstrating RNase 7 expression in hair follicle 
epithelium. The expression of RNase 7 in the uppermost epidermal layers and its 
expression in hair follicles are in concordance with its proposed antimicrobial 
function, because it is expressed at areas where the first contact with bacteria takes 
place. Higher RNase 7 protein levels were detected in the supernatants of the 
primary keratinocyte cultures compared with keratinocyte extracts. These data 
indicate that RNase 7 is secreted from viable cells and acts primarily outside the cell, 
which is consistent with the proposed role of RNase 7 in antimicrobial defense. 
Based on these in vitro data, it was speculated that RNase 7 is secreted in vivo on the 
body surface, so it was determined whether RNase 7 is present at various skin 
surface sites. Various amounts of RNase 7 in skin washing fluids from different body 
sites were recovered, which confirmed that RNase 7 is secreted in vivo. High 
variability in RNase 7 secretion levels was detected in different persons and skin 
locations. This suggests that levels of RNase 7 secretion may depend on 
environmental factors such as microbial colonization. 
The high expression of RNase 7 in skin and its very potent activity against E. 
faecium suggest that the skin is protected against colonization with E. faecium. This 
would explain the low infection rate of skin areas exposed to E. faecium such as the 
perianal region. Skin extracts derived from the stratum corneum efficiently killed E. 
faecium indicating that the skin harbors defense mechanisms which inhibit 
cutaneous colonization with E. faecium.  
 
4.4 Ribonuclease and antimicrobial activity 
The high antimicrobial activity of RNase 7 against E. faecium raises the 
question of the responsible molecular killing mechanisms and of the role of the 
ribonuclease activity. Recombinant RNase 7 that lacks enzymatic activity, by making 
point mutations of the catalytic residues lys-38 and his-123, was still potent for 
bactericidal activity against E. faecium. This is consistent with other reports showing 
that members of the RNase A superfamily exhibit ribonuclease-independent 
antibacterial activity, but raises the question of the role of the enzymatic activity. It 
has been shown that the antiviral activity of the RNases ECP and EDN against 
respiratory syncytial virus (RSV) requires functional ribonuclease activity. These data 
suggest that the ribonuclease activity of RNase 7 may be necessary for a potential 
antiviral rather than antibacterial activity. However, this remains to be proven as it is 
not yet known whether RNase 7 exhibits antiviral activity.  
The ribonuclease inhibitor interacts with RNase 7 and blocks its ribonuclease 
as well as antimicrobial activity. It is possible that the ribonuclease inhibitor masks 
the amino acid residues responsible for the antimicrobial action of RNase 7. Another 
explanation is that the interaction of the ribonuclease inhibitor RI induces a 
conformational change of RNase 7 as recently reported for the interaction of RNase 
1 and the ribonuclease inhibitor. 
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4.5 Functional domains of RNase 7 that influence its 
antibacterial activity 
The functional domains of RNase 7 influence its activity against bacteria. The 
generation of a series of RNase 7 fragments shows that contain different 
components of its secondary motifs starting from both the N-terminus and C-
terminus of RNase 7. Each fragment is determined to have antimicrobial properties 
against both Gram-positive S. saprophyticus and Gram-negative E. coli and P. 
mirabilis. However, RNase 7 fragments display significant differences in their 
antimicrobial activity profiles. Compared to N-terminal fragments, C-terminal 
fragments show uniformly decreased activity against Gram-negative E. coli, P. 
mirabilis, and Gram-positive S. saprophyticus. Fragments that lack β-sheet 1, 3 and 4 
also demonstrate significantly decreased activities. One fragment is found to have at 
least four-fold increased potency against both E.coli and Staphylococcus compared 
to full-length peptide. There are also identified distinct regions of the peptide that 
are independently responsible for Gram-negative and Gram-positive activity. These 
studies suggest that distinct mechanisms are responsible for RNase 7's antimicrobial 
activity against various pathogens. 
 
 4.6 Recombinant RNase 7 and comparison with RNase 3 
 Recombinant RNase 7 is ribonucleolytically active against yeast tRNA, as 
expected from the presence of eight conserved cysteines and the catalytic histidine–
lysine– histidine triad which are signature motifs of this superfamily. The protein is 
atypically cationic with an isoelectric point (pI) of 10.5. Expression of recombinant 
RNase 7 in Escherichia coli completely inhibits the growth of the host bacteria, 
similar to what has been observed for the cationic RNase, eosinophil cationic protein 
(ECP/RNase 3, pI 11.4). An in vitro assay demonstrates dose‐dependent cytotoxicity 
of RNase 7 against bacteria E.coli, Pseudomonas aeruginosa and Staphylococcus 
aureus. While RNase 7 and ECP/RNase 3 are both cationic and share this particular 
aspect of functional similarity, their protein sequence identity is only 40%. Of 
particular interest, ECP/RNase 3’s cationicity is based on an (over)abundance of 
arginine residues, whereas RNase 7 includes an excess of lysine. This difference, in 
conjunction with the independent origins and different expression patterns, suggests 
that RNase 7 and ECP/RNase 3 may have been recruited to target different 
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4.7 RNase 7 compared to RNase 8 
RNase 7 and RNase 8 share an amino acid sequence similarity of 78% and a 
genomic distance of only 15,000 bp, suggesting that they may have evolved from a 
common ancestor gene by a duplication event. However, although these proteins 
show a very high similarity in their gene and protein sequence, their physiological 
roles seem to be completely different. RNase 8 mRNA has been shown to be 
expressed uniquely in the placenta, and no antibacterial/antiviral activity could be 
detected with recombinant material. In contrast, RNase 7 is expressed in many 
epithelial tissues and exhibits a broad spectrum of efficient antimicrobial activity at 
low micromolar concentrations against various pathogenic microorganisms, 
includingS. aureus, P. aeruginosa, P. acnes, and C. albicans (lethal doses that achieve 
a CFU reduction of 90% (LD90) = 0.75–1.5 μM).  
 
 
4.8. Conclusion  
In conclusion, the isolation of a novel epithelial-derived antimicrobial RNase 
identifies RNases as a novel class of endogenous epithelial antimicrobial proteins 
that may play an important role in the innate immunity of human epithelia and offer 
an immediate host response against infectious agents. It is interesting to speculate 
that in patients suffering from recurrent epithelial infections the production of 
epithelial-derived antimicrobial proteins like RNase 7 might be disturbed. 
Finally, the discovery of human epithelial antimicrobial proteins like RNase 7 
may further inspire the development of new strategies for the treatment of 
infectious diseases in which conventional antibiotics fail because of the emergence 
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The work of this Thesis is part of a research project focused on the study of 
the structure-function relationship of RNase 7.  As it is already mentioned, this 
protein is an epithelial-derived antimicrobial RNase that exhibits ribonuclease 
activity and belongs to the ribonuclease A superfamily. It is expressed in various 
somatic and epithelial tissues and its main source of secretion is the keratinocyte 
cells of the skin.  
The aims of the presented work were:  
1)  Expression of the epithelial- derived RNase7 using E. Coli strains BL21, 
transformed with vector pET11c with insertion of synthetic gene. 
2) Isolation and purification of the protein from insoluble fraction (inclusion 
bodies). Purification was made through denaturation and renaturation steps, 
using FPLC (RESOURCE S column) or HPLC (MONO S column) as the final step 
of purification. 
3) Characterization of expressed and purified proteins with SDS polyacrilamide 
gel electrophoresis. 
4) Determination of the ribonuclease activity of purified proteins using 
electrophoretic method of SDS gel by zymogram, using poly(U) as a substrate. 
5) Evaluation of the antimicrobial activity by counting colonies in agar plates 
after mixing of diluted proteins with diluted bacteria and equilibration. 
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2. BIOLOGICAL MATERIAL AND CULTURE MEDIA 
 
2.1 Esherichia Coli as a host for pET11c for the expression of RNase7 
E. coli is Gram-negative, facultative anaerobic and non-sporulating. Cells are 
typically rod-shaped, and can live on a wide variety of substrates. Optimal growth 
of E. coli occurs at 37 °C, but some laboratory strains can multiply at temperatures of 
up to 49 °C. E. coli and related bacteria possess the ability to 
transfer DNA via bacterial conjugation, transduction or transformation, which allows 
genetic material to spread horizontally through an existing population.  
Escherichia coli encompass an enormous population of bacteria that exhibit a 
very high degree of both genetic and phenotypic diversity. E. coli is one of the most 
diverse bacterial species: only 20% of the genome is common to all strains. 
A strain is a sub-group within the species that has unique characteristics that 
distinguish it from other strains. These differences are often detectable only at the 
molecular level; however, they may result in changes to the physiology or lifecycle of 
the bacterium.  
In this experiment, the strain used as general host for Pt11c vector is the 
BL21 which has the genotype: F- omp t hsdSB(rB
-mB
-) gal dcm (DE3).  
 
2.2 Plasmids 
  A plasmid is a small DNA molecule that is physically separate from, and can 
replicate independently of, chromosomal DNA within a cell. Most commonly found 
as small circular, double-stranded DNA molecules in bacteria, plasmids are 
sometimes present in archaea and eukaryotic organisms. In nature, plasmids carry 
genes that may benefit survival of the organism, such as antibiotic resistance, and 
can frequently be transmitted from one bacterium to another, even of another 
species via horizontal gene transfer.  Artificial plasmids are widely used 
as vectors in molecular cloning, serving to drive the replication of recombinant DNA 
sequences within host organisms. 
 
2.3 Plasmids as vectors 
Plasmids used in genetic engineering are called vectors. Plasmids serve as 
important tools in genetics and biotechnology labs, where they're commonly used to 
multiply or express particular genes. Many plasmids are commercially available for 
such uses. The gene to be replicated is normally inserted in copies, into a plasmid 
that typically contains a number of features. The plasmid should include a gene that 
makes the bacterial cells resistant to particular antibiotics such as Kanamycin or 
Ampicillin. It should also contain at least one DNA sequence that serves as an origin 
of replication, or ori (a starting point for DNA replication), which enables the plasmid 
DNA to be duplicated independently from the chromosomal DNA  and to be 
distributed to the daughter cells, and a multiple cloning site (MCS, or polylinker). A 
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multiple cloning site is a short region containing several commonly used restriction 
sites allowing the easy insertion of DNA fragments at this location. An ideal vector 
should have a small size, a large number of restriction sites, marker genes for easy 
seletion of the clones containing the insert and promoters for in vitro transcription.  
After the gene of interest is inserted, the plasmids are inserted into bacteria 
by a process called transformation. Then, the bacteria are exposed to the particular 
antibiotics. Only bacteria that take up copies of the plasmid survive, since the 
plasmid makes them resistant. In particular, the protecting genes are expressed and 
the expressed protein breaks down the antibiotics. In this way, the antibiotics act as 
a filter to select only the modified bacteria. Now these bacteria can be grown in 
large amounts, harvested, and lysed to isolate the plasmid of interest. 
Another major use of plasmids is to make large amounts of proteins. In this 
case, researchers grow bacteria containing a plasmid harboring the gene of interest. 
Just as the bacterium produces proteins to confer its antibiotic resistance, it can also 
be induced to produce large amounts of proteins from the inserted gene. 
A plasmid can contain inserts of up to 30-40 kbp. To clone longer lengths of 
DNA, lambda phage with lysogeny genes deleted, cosmids, bacterial artificial 
chromosomes, or yeast artificial chromosomes are used. 
In this experiment pET11c vector is used for cloning in E. coli. pET11c plasmid  




Figure 1. The pET Vector. This plasmid contains a drug resistant marker for ampicillin 
resistance, the T7 transcription promoter, the lac operator region to the T7 
promoter, a lacI repressor ORF and a polylinker region with a Nde I cloning site,a 
BamH I cloning site and a ribosome binding site . There are two origins of replication 
- one is the f1 origin which enables the production of a single stranded vector under 
appropriate conditions, and the other is the conventional origin of replication. 
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2.4 Luria-Bertani (LB) medium (per 1 l) 
Luria-Bertani (LB) broth is the most widely used medium for the growth of 
bacteria. Life Technologies offers LB media in both powder and ready-to-use liquid 
formats for convenience and ease of use. 
PREPARATION : 10 g of bactotryptone, 5 g of bactoyeast extract and 10 g of 
NaCl are dissolved in 950 mL of deionised MQ water. Volume is adjusted in 1 L and 
sterilization is succeeded by autoclaving. Concentration of LB: 25 g/L. 
 
2.5 Terrific Broth (TB) medium (per 1 l) 
Terrific broth (TB) is a nutritionally rich medium for the growth of bacteria. 
Actually, it is a medium allowing the overexpression of the proteins and the 
formation of inclusion bodies. Life Technologies offers TB media in both powder and 
ready-to-use liquid formats for convenience and ease of use. 
PREPARATION : In 900 mL of deionised MQ water 12g of bactotryptone, 24g 
of bacto-yeast extract and 4 mL of glycerol are added followed by autocliving for 
sterilization. (glycerol is added last after solubilization is succeded). After solution is 
cooled down to 60 oC, 100 mL of 0.17 M KH2PO4 and 0.72 M K2HPO4 are added 
because if the TB medium is autoclived in the presence of phosphate buffer, a 
precipitate will occur. 
TB salts (10x) : 23.1g  KH2PO4 and 125.4 g  K2HPO4 are dissolved in water to 
a final volume of 1 L and are sterilized by autoclaving. 
Tryptone; Tryptone is commonly used to produce LB for the growth of E. 
coli and other microorganisms. It provides a source of amino acids for the growing 
bacteria. 
Bacto-yeast extract; BD Yeast Extracts are animal-free products suitable for 
use as multi-functional nutritional supplements in cell culture, microbial 
fermentation and insect cell culture applications. 
 Glycerol; Glycerol has three hydroxyl groups that are responsible for 
its solubility in water and its hygroscopic nature and is used as a carbon source. 
Buffer solution; An appropriate buffer solution added to a protein mixture 
during the extraction process can help improve the stability of protein molecules as 
these molecules are subjected to various forces designed to isolate them for study. A 
buffer solution can protect the integrity of the proteins while separating them from 
other integrated cell components. 
A buffer solution should be compatible with the protein in question and able 
to recreate an ionic environment similar to the ionic environment of the cell. The pH 
balance of the buffer must correspond with that of the cell in vivo, while still 
allowing separation of the cell’s component parts. 
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A buffer solution that can maintain protein stability during every stage of the 
procedure is necessary in order to avoid the need to switch buffer solutions during 
the process, including chromatography or electrophoresis. It’s also wise to account 
for shifts in temperature, since the pH of some buffer solutions can change in the 
presence of heat.  
 
2.6 IPTG induction 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) is a molecular biology reagent. 
This compound is a molecular mimic of allolactose, a lactose metabolite that 
triggers transcription of the lac operon and it is therefore used to induce protein 
expression where the gene is under the control of the lac operator. However, IPTG, 
unlike allolactose, is not hydrolyzable by β-galactosidase, its concentration therefore 
remains constant in an experiment.  
Like allolactose, IPTG binds to the lac repressor and releases the tetrameric 
repressor from the lac operator in an allosteric manner, thereby allowing the 
transcription of genes in the lac operon, such as the gene coding for beta-
galactosidase, a hydrolase enzyme that catalyzes the hydrolysis of β-galactosides 
into monosaccharides. But unlike allolactose, the sulfur (S) atom creates a chemical 
bond which is non-hydrolyzable by the cell, preventing the cell from metabolizing or 
degrading the inducer. The concentration of IPTG therefore remains constant and 




Figure 2. Chemical structure of 1,6-allolactose and its molecular mimic, IPTG 
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Figure 3. Production of recombinant proteins. (a) The expression vector contains 
the lac promoter and its neighboring lacZ gene encoding β-galactosidase. Lactose or 
its analog IPTG can stimulate the expression of β-galactosidase. (b) If lacZ is replaced 
by the gene encoding the protein of interest, lactose or IPTG will stimulate the 
expression of desired proteins 
 
2.7 Centrifugation for cell collection 
After the protein expression is achieved by induction with IPTG, the next goal 
is to start the purification of the protein. The first step in this long procedure is its 
separation from non-protein components such as nucleic acids, lipids or unbroken 
cells, through centrifugation, according to their size, shape, density, viscosity of the 
medium and rotor speed. In a solution, particles whose density is higher than that of 
the solvent sink (sediment), and particles that are lighter than it float to the top. The 
greater the difference in density, the faster they move.  
After centrifugation, the supernatant containing the soluble hydrophilic 
proteins is separated from the pellet containing the hydrophobic/insoluble proteins, 
such as the inclusion bodies. Inclusion bodies have a relatively high density and, 
therefore, can be pelleted by centrifugation. 
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2.8 Inclusion bodies 
Overproduction of heterologous proteins in the cytoplasm of E. coli is often 
accompanied by their misfolding and segregation into insoluble aggregates known as 
inclusion bodies.  
It has been possible to develop improved solubilization and refolding 
procedures for higher recovery of bioactive protein. Proteins inside inclusion body 
aggregates have native-like secondary structures, but remain inactive and 
denatured. It is assumed that restoration of this native-like secondary structure 
using mild solubilization conditions will help in improved recovery of bioactive 




 the recombinant protein deposited in     
inclusion bodies can be 50% or more of the 
total cellular protein. 
 
refolding is often cumbersome and 
optimal condition cannot be 
predicted 
the inclusion bodies often contain almost 
exclusively the overexpressed protein. 
 
 
in inclusion bodies the protein is protected 
from proteolytic degradation. 
 
 
expression in inclusion bodies will protect the 
cell against the toxicity of the recombinant 
protein 
 
Table 1. Advantages and disadvantages of inclusion bodies for protein purification. 
 
Experimental procedure 
1) A small quantity of the desired cells ( E. Coli BL21) which are stored at  -80oC 
are inoculated in 500 mL of LB medium for the overnight culture of bacteria, 
along with ampiciline (amp) (100 μg/mL). 
2) Overnight incubation  in 37oC shaker. 
3) 200 mL of KH2PO4/ K2HPO4 through a sterilized with water tube are added, 
along with 8 mL amp and 40 mL bacteria of the overnight culture  to 
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inoculate 2l of TB and are grown at 37oC until an OD600 of approximately 0.6 
is reached. 
4) 1.250 μL IPTG at a final concentration of 1 mM are added to induce the 
protein expression. 
5) The culture is incubated at a suitable temperature, under stirring for a period 
of 3 – 4h.  
6) Before and after the IPTG induction aliquots are taken to confirm the 
recombinant protein expression by SDS-PAGE analysis and are centrifuged at 
14.800 rpm for 1 minute. 
7) The culture is centrifuged for 10 minutes at 12.000 rpm. 
8) The supernatant is discarded and the pellet is kept in fridge at -20 oC to be 






 In order to start the purification of our protein which is obtained from 
the inclusion bodies that are formed in the sediment, it is necessary to move on to 
cell disintegration or lysis. The goal of lysis is to disrupt parts of the cell wall or the 
complete cell to release biological molecules, such as organelles, proteins, DNA, 
mRNA.  It is important that cell lysis is complete, because intact cells sediment 
together with the inclusion bodies, thus contaminating the preparation. 
In the case of sonication for cell lysis, ultrasound high-frequency sound waves 
are applied to samples to agitate and disrupt the cell membranes. Whether the 
disruption is very gentle or very abrupt depends on the cell structure and on the 
purpose of lysis (e.g. DNA extraction requires softer sonication, complete protein 
extraction of bacteria requires a more intense ultrasound treatment), so the 
duration of sonication is regulated according to the purpose served. Localized 
heating due to the high-frequency waves can occur leading to protein denaturation 
and aggregation. To avoid this problem it is essential to keep samples on ice. 
The buffer in which the pellet is resuspended  before the sonication, is used 
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1) The pellet is resuspended with the following buffer, so the total volume will be 
around 80 mL, while the initial volume of the culture was 2l and then is mixed with 
vortex. 
Buffer:  
 10 mM Tris HCl pH 8.0  
(for providing an ionic environment similar to that of the cell in vivo so as the  
stability of the  protein is maintained ) 
 2 mM EDTA ( for prevention of proteases) 
2) The sample is inserted in tubes.  
3) Each tube is sonicated  3 times for 6 minutes while kept on ice to avoid 
destruction of the proteins. 
4) The sample is then centrifuged for 30 minutes  at 16.000 rpm at 4 oC. 
5) The supernatant is discarded and the pellet is kept in fridge. 
 
 
2.9.2 Purification from inclusion bodies through denaturating 
and refolding steps 
To obtain soluble active proteins from inclusion bodies, the insoluble 
inclusion bodies are first washed. This wash step is necessary to remove 
contaminants, especially proteases that may have absorbed onto the hydrophobic 
inclusion bodies during processing. Then, they are solubilized in denaturant form and 
are centrifuged to remove remaining aggregates which could act as nuclei to trigger 
aggregation during refolding. Then the denaturant is reduced and removed from the 
solubilized protein by dilution in a huge volume of refolding buffer to recover soluble 
and active proteins.  
For this reason, denaturing buffer containing Guanidine hydrochloride 
denaturant is most commonly used to solubilize the inclusion bodies in denature 
form. Guanidine hydrochloride can unfold the misfolded secondary structures 
present in inclusion bodies completely into random coiled structures. Then, 
glutathione, which acts as a reducing agent, is added in the denaturing buffer, with 
which the inclusion bodies are incubated. 
Glutathione (GSH) is an important antioxidant in plants, animals, fungi and 
some bacteria and archaea, preventing damage to important cellular components 
caused by reactive oxygen species such as free radicals and peroxides. It is 
a tripeptide of  L-cysteine, L-glutamic acid, and glycine with a gamma peptide linkage 
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between the carboxyl group of the glutamate side-chain and the amine 
group of cysteine (which is attached by normal peptide linkage to a glycine). 
Glutathione exists in both reduced (GSH) and oxidized (GSSG) states. In the 
reduced state, the sulfhydryl (thiol) group (SH) group of cysteine is able to donate 
a reducing equivalent (H++ e−) to other unstable molecules, reducing  disulfide bonds 
formed within cytoplasmic proteins to cysteines by serving as an electron donor.In 
donating an electron, glutathione is converted to its oxidized form, becoming itself 
reactive, so it reacts with another reactive glutathione to form glutathione 
disulfide (GSSG), also called L – glutathione. 
So, in our experiment the reduced glutathione in the denaturing buffer 
donates its hydrogen in the proteins, cleaving the disulfide bonds formed between 
them, thus helping in the unfolding process. However, in the refolding buffer the 
oxidised form of glutathione, has no hydrogens, so it takes them back from the 
proteins, letting the formation of disulfide bonds between the proteins, meaning 
that they are refolded again. The best yield was obtained when the GSH / GSSH ratio 
was 4. The refolding buffer also contains Tris-HCl and L-arginine, which impedes 
aggregate formation by enhancing the solubility of folding intermediates, 









1) The pellet is resuspended in 20 mL of the following buffer and then mixed 
with vortex for 30 minutes 
 
Buffer:  
 50 mM Tris HCl pH 8.0  
 300 mM NaCl 
 2 mM EDTA 
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2) The sample is then centrifuged for 30 minutes  at 12.000 rpm at 4 oC. 
3) The supernatant is discarded and the pellet is kept in fridge. 
4) 25 mL of the following buffer is added gradually in the pellet in order to 
be resuspended. 
 
Denaturing buffer:  
 6  M Guanidine – HCl 
 100 mM Tris - acetate  pH 8.0 
 2 mM EDTA 
5) After the pH is checked to be ensured that is still 8.0 reduced glutathion is 
added to the final concentration of 80 mM.  Since   after the glutathion 
the  pH starts decreasing, at the same time solid Tris (hydroxymethyl) 
aminomethane is added in order to be kept stable (8.0). 
6) The solution is covered with parafilm and is left being sterilized for 2 h in 
nitrous atmosphere. 
7) Then, centrifugation follows in 12.000 rpm for 30 minutes. 
8) This time the pellet is discarded and the supernatant is kept. 
9) The supernatant is incubated gradually (5 mL / min) in 2 l of the following 
buffer, which is  kept in the fridge. (sample A) 
 
Refolding buffer: 
 100 mM Tris - acetate HCl pH 7,5 
 0,5 M L - arginine 
 0,3 mM L – glutathione 
 
 
2.9.3  Chromatographic purification of RNase 7 with ion 
exchanged chromatography (cationic) 
Purification and characterization of target proteins were then carried out by 
using high-resolution ion-exchange chromatography and SDS-PAGE gel, respectively. 
Ion-exchange chromatography (IEX) is a process that allows the separation 
of ions and polar molecules based on their affinity to the ion exchanger. It can be 
used for almost any kind of charged molecule including large proteins, small 
nucleotides and amino acids, offering high resolution and group separations with 
high loading capacity. The technique is capable of separating molecular species that 
have only minor differences in their charge properties. The solution to be injected is 
usually called a sample, and the individually separated components are 
called analytes. 
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Ion-exchange chromatography retains analyte molecules on the column based 
on coulombic (ionic) interactions. The stationary phase surface displays ionic 
functional groups (R-X) that interact with analyte ions of opposite charge. This type 
of chromatography is further subdivided into cation exchange chromatography and 
anion exchange chromatography. The ionic compound consisting of the cationic 
species M+ and the anionic species B- can be retained by the stationary phase. 
Cation exchange chromatography retains positively charged cations because the 
stationary phase displays a negatively charged functional group: 
 
Anion exchange chromatography retains anions using positively charged 
functional group: 
 
 In this experiment, two cation exchange columns are used : DEAE – 
sepharose and CM – sepharose (figure 5). DEAE-Sepharose consists of the anion-
exchange reactive group , diethylaminoethanol (DEAE) covalently linked to 
Sepharose (a polysaccharide polymer). DEAE is positively charged due to the 
presence of the amino-group (NH3
+). So, it binds negatively charged proteins and 
allows positively charged proteins to pass through the column, such as RNase 7. 
Then, CM – sepharose is used, which is negatively charged due to the presence of 
the carboxyl group (COO-), thus letting the binding of the positively charged proteins. 
The eluting solution passing through the columns has a p.H of 7.5, so RNase 7 with a 
p.I of 9.8 is positively charged. 
 The column is flushed with deionised MQ water, so that the storage solution 
(usually 20% ethanol) is washed out. 
 Equilibration with buffer A (150 mM sodium acetate pH 5.0) , to allow the 
binding with RNase 7.  
 Filtration of sample A so as to be condensed and prevent loading of 
misfolded proteins in the column. After filtration, it is loaded in the column. 
 The washout of columns by the same buffer follows (buffer A) for 5h for the 
removal of all proteins, which did not bind at the column. 
 Elution of the protein from the CM – sepharose column (which is negatively 
charged) with the use of NaCl linear gradient. More specifically, the column is 
connected with 2 solutions. The one contains  buffer A , 5 mM EDTA , 20 mM 
DTT prevents aggregation (buffer B) and the other buffer B and NaCl pH 5, 
2M, V=200 mL (figure 6). With this way, sodium chloride is transferred 
gradually in the column, so with the gradual increase of ionic strength, the 
proteins are removed from the column depending on the strength of their 
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binding to it. The proteins which are weakly bound in the column will elute 
first, while the ones that are bound will be retained and eluted in the last 
fractions, which contain the highest concentration of salt. 
 After the column has been used, it is washed with distilled deionised water, 
kept in 20% ethanol to prevent microbial growth and is stored at 4 oC. The 
flow rate of the sample was 2 mL/min and the fraction size was 4 mL. 
 The protein concentration of the fractions is calculated by measuring their 
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2.10 Characterization by SDS – polyacrylamide gel 
electrophoresis 
The term electrophoresis refers to the movement of charged molecules in 
response to an electric field, resulting in their separation. 
In an electric field, proteins move toward the electrode of opposite charge. The 
rate at which they move (migration rate,) is governed by a complex relationship 
between the physical characteristics of both the electrophoresis system and the 
proteins. Factors affecting protein electrophoresis include the strength of the 
electric field, the temperature of the system, the pH, ion type, and concentration of 
the buffer as well as the size, shape, and charge of the proteins. Proteins come in a 
wide range of sizes and shapes and have charges imparted to them by the 
dissociation constants of their constituent amino acids. As a result, proteins have 
characteristic migration rates that can be exploited for the purpose of separation. 
Protein electrophoresis can be performed in either liquid or gel-based media and can 
also be used to move proteins from one medium to another. 
Gel electrophoresis is a method for separation and analysis of 
macromolecules (DNA, RNA and proteins) and their fragments, based on their size 
and charge. It is used in clinical chemistry to separate proteins by charge and/or size 
(IEF agarose, essentially size independent) and in biochemistry and molecular 
biology to separate a mixed population of DNA and RNA fragments by length, to 
estimate the size of DNA and RNA fragments or to separate proteins by charge. 
Nucleic acid molecules are separated by applying an electric field to move the 
negatively charged molecules through an agarose matrix. Shorter molecules move 
faster and migrate farther than longer ones because shorter molecules migrate more 
easily through the pores of the gel. This phenomenon is called sieving. Proteins are 
separated by charge in agarose because the pores of the gel are too large to sieve 
proteins.  
Gel electrophoresis uses a gel as an anticonvective  and/or sieving medium 
during electrophoresis, the movement of a charged particle in an electrical field. Gels 
suppress the thermal convection caused by application of the electric field, and can 
also act as a sieving medium, retarding the passage of molecules; gels can also 
simply serve to maintain the finished separation, so that a post electrophoresis stain 
can be applied. 
Electrophoresis is a process which enables the sorting of molecules based on 
size. Using an electric field, molecules  can be made to move through a gel made of 
agar or polyacrylamide. The electric field consists of a negative charge at one end 
which pushes the molecules through the gel, and a positive charge at the other end 
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that pulls the molecules through the gel. The molecules being sorted are dispensed 
into a well in the gel material. The gel is placed in an electrophoresis chamber, which 
is then connected to a power source. When the electric current is applied, the larger 
molecules move more slowly through the gel while the smaller molecules move 
faster. The different sized molecules form distinct bands on the gel.  
If several samples have been loaded into adjacent wells in the gel, they will 
run parallel in individual lanes. Depending on the number of different molecules, 
each lane shows separation of the components from the original mixture as one or 
more distinct bands, one band per component. Incomplete separation of the 
components can lead to overlapping bands, or to indistinguishable smears 
representing multiple unresolved components. Bands in different lanes that end up 
at the same distance from the top contain molecules that passed through the gel 
with the same speed, which usually means they are approximately the same size. 
There are molecular weight size markers available that contain a mixture of 
molecules of known sizes. If such a marker was run on one lane in the gel parallel to 
the unknown samples, the bands observed can be compared to those of the 
unknown in order to determine their size. The distance a band travels is 
approximately inversely proportional to the logarithm of the size of the molecule. 
In most cases, the gel is a cross-linked polymer whose composition and 
porosity is chosen based on the specific weight and composition of the target to be 
analyzed. When separating proteins or small nucleic acids (DNA, RNA, or 
oligonucleotides) the gel is usually composed of different concentrations of 
acrylamide and a cross-linker, producing different sized mesh networks of 
polyacrylamide. When separating larger nucleic acids (greater than a few hundred 
bases), the preferred matrix is purified agarose. In both cases, the gel forms a solid, 
yet porous matrix. Acrylamide, in contrast to polyacrylamide, is a neurotoxin and 
must be handled using appropriate safety precautions to avoid poisoning. Agarose is 
composed of long unbranched chains of uncharged carbohydrate without cross links 
resulting in a gel with large pores allowing for the separation of macromolecules and 
macromolecular complexes. 
The types of gel most typically used are agarose and polyacrylamide gels. 
Each type of gel is well-suited to different types and sizes of analyte. Polyacrylamide 
gels are usually used for proteins, and have very high resolving power for small 
fragments of DNA (5-500 bp). Agarose gels on the other hand have lower resolving 
power for DNA but have greater range of separation, and are therefore used for DNA 
fragments of usually 50-20,000 bp in size, but resolution of over 6 Mb is possible 
with pulsed field gel electrophoresis. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
which is used in this experiment, is a technique for separating proteins based on 
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their ability to move within an electrical current, which is a function of the length of 
their polypeptide chains or of their molecular weight. It uses a discontinuous 
polyacrylamide gel as a support medium and sodium dodecyl sulfate (SDS) to 
denature the proteins. 
SDS  is an anionic detergent, meaning that when dissolved, its molecules have 
a negative charge within a wide pH range. A polypeptide chain binds amounts of SDS 
in proportion to its relative molecular mass. The negative charges on SDS destroy 
most of the complex structure of proteins, and are strongly attracted toward an 
anode (positively-charged electrode) in an electric field. 
If the proteins are denatured and put into an electric field, they will all move 
towards the positive pole at the same rate, with no separation by size. So we need to 
put the proteins into an environment that will allow different sized proteins to move 
at different rates. The environment of choice is polyacrylamide, which is a polymer 
of acrylamide monomers. When this polymer is formed, it turns into a gel and we 
will use electricity to pull the proteins through the gel so the entire process is called 
polyacrylamide gel electrophoresis (PAGE). 
In this system, two sequential gels are actually used; a stacking gel 
component, which has a low (5.5%) acrylamide concentration to make a porous gel. 
Under these conditions proteins separate poorly but are focused as  thin, sharply 
defined bands at the beginning of the electrophoretic run. The lower gel, called 
separating or resolving gel has a higher polyacrylamide content, which causes the gel 
to have narrower channels or pores. So, it separates the proteins based on their 
mass weight, allowing smaller proteins to travel more easily and hence rapidly, than 
larger proteins. This classic system uses a discontinuous buffer system where the pH 
and ionic strength of the buffer used for running the gel (Tris pH 8.3) is different 
from the buffers used in the stacking gel (Tris, pH 6.8) and resolving gel (Tris, pH 
8.8).  
After the electrophoresis is complete, the molecules in the gel can be stained  
to make them visible. DNA may be visualized using ethidium bromide which, when 
intercalated into DNA, fluoresce under ultraviolet light, while protein may be 
visualised using silver stain or Coomassie Brilliant Blue dye. 
Protein separation by SDS-PAGE can be used to estimate relative molecular 
mass, to determine the relative abundance of major proteins in a sample, and to 
determine the distribution of proteins among fractions. The purity of protein 
samples can be assessed and the progress of a fractionation or purification 
procedure can be followed. 
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1) Two glass plates are washed and then are put together in the electrophoresis 
chamber.  
2) Then, the separating gel is prepared and fills the gap between the glass plates 
(75% of the space), with the help of a pipette. 
3) The gel is covered with isopropanol until its polymerization (30 – 60 minutes). 
4) Isoporopanol is removed and the stacking gel is then added above the 
separating gel, filling the space up to the surface of the plates. 
5) A plastic comb is used to squize the gel in order to form a specified number 
of  wells. 
6) After polymerization of the second gel, the plastic comb is removed and the 
gel is placed in the electrophoresis device. 
7) In the meantime, 20 μL of each sample are mixed with 10 μL loading buffer 
(30% glycerol, 9% SDS, 15% β – mecraptoethanol, 0.05% bromophenol blue 
dissolved in Tris/HCl 180mM, pH 6.8). For the marker, 10 μL are mixed with 5 
μL loading buffer. 
8) The samples are heated for 2 – 3 min at 100oC. 
9) Running buffer 1x (250 mM Tris/HCl, pH 8.3, 1.9 M glycin, 1% SDS and 
distilled water up to 1 L) is poured in the device but not until the top. 
10) The samples are loaded in the wells, using a microsyringe and then the rest of 
the running buffer is poured. 
11) The device is connected with the power supply and the electrophoresis stops 
when the dye of the protein wells reaches about 1cm from the edge of the 
gel. 
12) After the device is removed from the power supply the plates are removed 
and are laid down in paper.  
13) Then they are carefully removed and the gel is placed in in Coomasie Brilliant 
Blue staining solution (30% methanol, 8% acetic acid, 0.15% Coomasie blue) 
for 10 min, while left shaking mildly. 
14) After the removal of the coomasie, destaining is performed with a solution of 
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For 2 gels (15%) For 1 gel (15%) 
2,5 mL H2O 1,25 mL H2O 
2,5 mL solution B ( 1,5 M 
Tris/HCl, pH 8.8, 0.4% SDS) 
1,25 mL solution B 
5 mL solution A ( 30.4% 
acrylamide, 0.8% bis – 
acrylamide) 
2,5 mL solution A 
40 μL APS (10%) 20 μL APS(10%) 
10μl TEMED 5μl TEMED 
Stacking gel 
1,9 mL H2O 
0,775 mL solution C 
0,5 mL solution A 
40 μL APS 
5 μL TEMED 
Table 2. Reagents for the preparation of the separating and stacking gel. 
 
 Bisacrylamide (N,N'-Methylenebisacrylamide) (C7H10N2O2) ; Bisacrylamide is the 
most frequently used cross linking agent for polyacrylamide gels, and is present 
in much smaller quantities than acrylamide. Chemically it can be thought of as 
two acrylamide molecules coupled head to head at their non-reactive ends. 
Bisacrylamide can crosslink two polyacrylamide chains to one another, thereby 
resulting in a gel. 
 Sodium Dodecyl Sulfate (SDS) (C12H25NaO4S); as it is already mentioned, SDS is a 
strong anionic detergent agent used to denature native proteins to unfolded, 
individual polypeptides. It binds around the polypeptide backbone, so, in this 
process, the intrinsic charges of polypeptides becomes negligible when 
compared to the negative charges contributed by SDS. Thus polypeptides after 
treatment become rod-like structures possessing a uniform charge density. The 
electrophoretic mobility of these proteins is a linear function of the logarithms of 
their molecular weights. Without SDS, different proteins with similar molecular 
weights would migrate differently due to differences in mass-charge ratio, as 
each protein has an isoelectric point and molecular weight particular to 
its primary structure.  Adding SDS solves this problem, as it binds to and unfolds 
the protein, giving a near uniform negative charge along the length of the 
polypeptide. 
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 Ammonium persulfate (APS) (N2H8S2O8); APS is a source of free radicals and is 
often used as an initiator for gel formation. 
  TEMED (N, N, N', N'-tetramethylethylenediamine) (C6H16N2); TEMED stabilizes 
free radicals and improves polymerization. The lowest catalytic concentrations 
that allow polymerization in a reasonable period of time should be used. Since 
the combination of APS and TEMED is essential for the polymerization of the gel, 
these reagents are added just before the transfer of the solutions in the plates. 
 Isopropanol; Right after the seperating gel is placed among the glass plates, 
isopropanol is added, so as to exclude air and to obtain an even interface 
between the gels. 
 Loading buffer; All protein samples before electrophoresis are mixed with 
loading buffer, which helps weigh down the solution, so that it can sink into the 
bottom of the wells and not float in the buffer solution. Bromphenol blue does 
not stain the samples, but helps their visualisation while loading them. The 
loading buffer, also contains a dense substance, such as glycerol. It is the glycerol 
which due to its density will make the sample more dense than the buffer which 
the gel is run in, and will prevent it floating out of the well. β-mercaptoethanol, 
which is also present n the loading buffer, is used to break disulphide bonds. 
 Running buffer; The gel is immersed within an electrophoresis buffer that 
provides ions to carry a current and some type of buffer to maintain the pH at a 
relatively constant value. 
 Coomassie Brilliant Blue R-250 (CBB) (C45H44N3NaO7S2). CBB is the most popular 
protein stain. It is an anionic dye, which non-specifically binds to proteins. The 
structure of CBB is predominantly non-polar, and it is usually used in methanolic 
solution acidified with acetic acid. Proteins in the gel are fixed by acetic acid and 
simultaneously stained. The excess dye incorporated into the gel can be 
removed by destaining with the same solution without the dye. The proteins are 
detected as blue bands on a clear background. As SDS is also anionic, it may 
interfere with staining process. Therefore, large volume of staining solution is 
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2.11 Ribonuclease activity by zymogram 
Zymography is an electrophoretic method, based on SDS-PAGE, used for 
measuring proteolytic activity. It includes an enzyme substrate copolymerized with 
the polyacrylamide gel. Samples are prepared without boiling to preserve the 
structure and activity of the enzyme. Following electrophoresis, the gel is placed in 
an enzyme activation buffer which allows the enzymes present in the sample to 
become active and digest the substrates copolymerised in the gel. The zymogram is 
subsequently stained, and areas of digestion appear as clear bands against a darkly 
stained background where the substrate has been degraded by the enzyme. 
In this experimental work, the separating gel consists of certain amount of 
polyurydylic acid (poly(U)) as a substrate, in order to determine bands which 
correspond to the protein fractions with ribonuclease activity. Since it is mixed with 
other reagents, it is applied everywhere in the gel, meaning that enzymes with 
ribonuclease activity in contact with poly(U), locally degrade the polynynucleotide 
and are represented as clear bands in the gel. After the separations of the proteins 
by electrophoresis, the gel is washed with three different solutions, playing different 
roles each. The first solution (solution 1) contains isopropanol and is used to remove 
SDS, while the second (solution 2) is used to remove the isopropanol. The third 
solution (solution 3), containing an increased concentration of Tris, compared to the 
other two, increases the ionic charge of the protein, thus providing the best 
conditions for the expression of the ribonuclease activity. The gel is then stained 
with toluidine blue, allowing the visualization of the bands representing the 
ribonuclease activity, which remain without dye. 
 
Experimental procedure  ( quantities for 2 gels)  
1)  6 mg of poly(U) (potassium salt of poly(U): SIGMA) are diluted  in 2,5 mL of 
distilled water. 
2) The soution is left for 10 minutes at room temperature and then 5 minutes at 
55 oC. 
3) 5 mL of solution A (same as SDS-PAGE) and 2,5 mL of solution B (same as SDS-
PAGE) are heated for 1 – 2 min at 55oC, so as to have the same temperature 
with the poly (U) substrate, with which are mixed  together. 
4) 10 μL TEMED and 40 μL of APS are added. 
5) 5 mL of separating gel is poured with a pipette between glasses in 
electrophoretic kit without forming bubbles. 
6)  The separating gel is covered with certain quantity of isopropanol and is left 
for approximately 30 min. to be polymerized. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 10:16:14 EET - 137.108.70.7
41 
 
7) The stacking gel (the same with SDS – PAGE electrophoresis) is prepared and 
after the removal of the isopropanol, is placed between the plates forming 
the upper layer above the separating gel, reaching up to the surface of the 
plates. 
8)  A plastic comb is used to squize the gel in order to form a specified number 
of  wells. 
9) After polymerization of the second gel, the plastic comb is removed and the 
gel is placed in the electrophoresis device. 
10)  The samples are mixed  with loading buffer (without β - mercaptoethanol) in 
the ratio sample/buffer 2 to 1 and  are loaded in the wells ( no more than 15 
μL), using a microsyringe. 
11) The device is connected with the power supply and the electrophoresis stops 
when the dye of the protein wells reaches about 1cm from the edge of the 
gel. 
12) The gel is washed with solution 1; cooled buffer Tris/HCl 10 mM, pH 7.5 
which has 20%  isopropanol (3 times for 5 – 10 min) 
13)  The gel is washed with solution 2; cooled buffer containing 10 mM Tris/HCl,  
pH 7.5 (3 times for 5 – 10 min) 
14) The gel is incubated at room temperature with solution 3;  buffer containing 
100 mM Tris/HCl for 1 hour. 
15) The gel is stained for 10 min with toluidine blue (0.2% toluidine blue in   




2.12 Antimicrobial activity 
In order to determine, if RNase 7 shows antimicrobial activity, the Diffusion 
or agar plate method is performed. The proteins are mixed with the bacteria, after 
both of them are diluted and then, after incubation they are spread in agar plates to 
be incubated. Then, the bacterial colonies are measured in each plate and the 
minimum inhibitory concentration (MIC) is calculated. MIC is the lowest 
concentration of an antimicrobial that will inhibit the visible growth of an organism 
after overnight incubation. MIC is important to confirm resistance of microorganisms 
to an antimicrobial agent, such as RNase 7 in our case, and also to monitor the 
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Experimental procedure   
1) Initially, the agar plates are prepared; 12,5 gr of L.B and 7,5 gr of agar are 
dissolved in 0,5 L of water. Then, they are sterilized for 20 minutes at 120oC 
(dry heat). Last, after the medium is cooled, it is shared in 10 plates and left 
in room temperature until it is solidified. 
2) Bacterial dilution 
10 μL of E. Coli is added in 990 μL of buffer in an eppendorf type tube. Then, 
10 μL are added in 990 μL of buffer and the same procedure follows one 
more time so the final dilution is 1/10.000. 
3) Protein dilution   
The initial concentration of RNase 7 is 62 mM, while the final concentration 
should be 20 mM in 100 μL. So, according to the type C1XV1 = C2V2, 32 μL of 
RNase 7 are added in 68 μL of buffer in the first eppendorf type tube. Then, 
50 μL of the dilution of the first eppendorf type tube are added in a second 
eppendorf type tube which already contains 50 μL buffer. The same 
procedure goes on for n=10 eppendorf type tubes and 50 μL of the last 
eppendorf type tube are discarded, so each eppendorf type tube finally 
contains 50 μL. In each step, the concentration of the protein is reduced by 
half. 
4) Mixing of RNase 7 with diluted bacteria 
In every eppendorf type tube containing 50 μL  (protein+buffer), 50 μL of 
diluted bacteria are added. 
5) The eppendorf type tubes are incubated at 37 oC for 4 h. 
6) The incubated bacteria solution is spread in agar plates (25 μL per plate) and 
is left at 37 oC for 12 h. 
7) The colonies are measured and the c/50 is calculated through a computer 
programme. 
The plates, in which no bacteria growth is found, represent the antimicrobial activity 





Crystallization is the process for the formation of solid crystals from an 
homogenous solution. More than 80% of the substances used in pharmaceuticals, 
fine chemicals, agrochemicals, food and cosmetics are isolated or formulated in 
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their solid form. Crystallization is in general the last chemical purification step in the 
production of ingredients. 
 
Crystallization of proteins is a biochemical technique, which is originally used 
to isolate and control the purity of the proteins, as the small crystallinity of 
molecules is indication of purity. Proteins, like many other molecules, can be 
prompted to form crystals, when the solution in which they are dissolved becomes 
supersaturated. Under these conditions, individual protein molecules can pack in a 
repeating array, held together by noncovalent interactions. The goal of 
crystallization is usually to produce a well-ordered crystal that is lacking in 
contaminants and large enough to provide a diffraction pattern when hit with x-ray. 
This diffraction pattern can then be analyzed to discern the protein’s three-
dimensional structure. Solving the three-dimensional (3D) structure of a protein 
represents a prerequisite and critical step towards complete understanding of its 
biological function. In addition, knowledge of the 3D structure is useful for research 
areas that rely on protein structure, such as rational protein design, bioinformatics, 
biodiversity, and studies on mechanisms of human health and disease.  
Crystallization of protein molecules has been known for over 150 years. In 
1934, John Desmond Bernal and his student Dorothy Hodgkin discovered that 
protein crystals surrounded by their mother liquor gave better diffraction patterns 
than dried crystals. Using pepsin, they were the first to discern the diffraction 
pattern of a wet, globular protein. Prior to Bernal and Hodgkin, protein 
crystallography had only been performed in dry conditions with inconsistent and 
unreliable results. In 1958, the structure of myoglobin, determined by X-ray 
crystallography, was first reported by John Kendrew, who also won a Nobel Prize in 
Chemistry in 1962 for this discovery. The interest of X-ray diffractionists was 
influential in promoting efforts to reproducibly grow high quality protein crystals, 
but also led to efforts to increase success rates and to automate the crystallization 
process. The background for the latter is formed by the fact that with the 
extraordinary advances in data collection and computing techniques and with the 
revolution in pharmacology and biotechnology, the need for new macromolecular 
crystals very soon greatly surpassed their supply.  Clearly, at present, the challenge is 
to obtain enough knowledge about the ideal conditions for protein crystallization, 
initially through the ‘trial-and-error’ principle and then, based on this knowledge, to 
develop new, more directed methods in order to be able to readily crystallize any 
protein.  
Proteins are biological macromolecules and function in an aqueous 
environment, so protein crystallization is predominantly carried out in water. Protein 
crystallization is traditionally considered challenging due to the restrictions of the 
aqueous environment and the fragile nature of protein crystals. Proteins have 
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irregularly shaped surfaces, which results in the formation of large channels within 
any protein crystal. Therefore, the noncovalent bonds that hold together the lattice 
must often be formed through several layers of solvent molecules. In addition to 
overcoming the inherent fragility of protein crystals, the successful production of X-
ray worthy crystals is dependent upon a number of environmental factors because 
so much variation exists among proteins, with each individual requiring unique 
conditions for successful crystallization. Therefore, attempting to crystallize a protein 
without a proven protocol can be very tedious. Some factors that require 
consideration are protein purity, pH, and concentration of protein, temperature, and 
precipitants. In order for sufficient homogeneity, the protein should usually be at 
least 97% pure. pH conditions are also very important, as different pH’s can result in 
different packing orientations. Buffers, such as Tris-HCl, are often necessary for the 
maintenance of a particular pH. Precipitants, such as ammonium sulfate or 
polyethylene glycol, are compounds that cause the protein to precipitate out of 
solution. Specifically, the factors which affect crystallization, are presented in the 
following table. 
 
Physical factors   Chemical factors Biochemical factors  
 
Temperature Precipitant type Sample purity 
Methodology  Precipitant concentration Macromolecular 
impurities 
Time  pH and buffer Aggregation  
Pressure  Ionic strength Posttranslational 
modifications 




Sample source  
 
Vibrations and sound Sample concentration Sample storage 
Magnetic fields Metal ions Proteolysis 
Electric fields Detergents Chemical modifications 
Dielectric properties Small molecule impurities Sequence modifications 
Viscosity Polyions Sample symmetry 
Equilibration rate Crosslinkers Sample pI 
Nucleants Heavy metals Sample history 




Reagent purity Microbial contamination  
 
Surface of crystallization 
device 
Reagent formulation Purification method  
 
Sample handling   
Table 3. Factors that affect crystallization 
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2.13.1 The thermodynamics of crystal growth 
Crystallization is a complex process, involving multiple equilibria between 
different states of the crystallizing species. The three stages of crystallization 
common to all molecules are nucleation, crystal growth and cessation of growth. 
During nucleation enough molecules associate in three dimensions to form a 
thermodynamically stable aggregate, the so called critical nucleus. These nuclei 
provide surfaces suitable for crystal growth, which can occur by a couple of different 
mechanisms. Crystal growth ceases when the solution is sufficiently depleted of 
protein molecules, deformation-induced strain destabilizes the lattice, or the 
growing crystal faces become poisoned by impurities. 
The solubility of a solute is the maximum amount of solute that can be 
dissolved in a given amount of solvent at a given temperature. 
 A saturated solution is a solution in which no more solute can be dissolved at 
a given temperature. 
 An unsaturated solution is a solution into which more solute can be 
dissolved. 
 A supersaturated solution is an unstable solution as it contains more 
dissolved solute than a saturated solution. 
A classical explanation of crystal nuclei formation and growth is given by the 
two-dimensional solubility diagram shown in figure 7. The solubility curve divides the 
concentration space into two areas - the undersaturated and supersaturated zones. 
Each point on this curve corresponds to a concentration at which the solution is in 
equilibrium with the precipitating agent. These correspond to the situation either at 
the end of the crystal growth process from a supersaturated solution or to a 
situation when crystal dissolution occurs in an undersaturated solution. In the area 
under the solubility curve, the solution is undersaturated and the crystallisation will 
never take place. Above the solubility curve lies the supersaturation zone; here, for a 
given concentration of precipitating agent, the protein concentration is higher than 
that at equilibrium. Depending on the kinetics to reach equilibrium and the level of 
supersaturation, this region may itself be subdivided into three zones: 
1. The precipitation zone is where the excess of protein molecules immediately 
separates from the solution to form amorphous aggregates. 
2. The nucleation zone is where the excess of protein molecules aggregates in a 
crystalline form. Near the precipitation zone, crystallisation may occur as a 
shower of microcrystals, which can be confused with precipitate. 
3. A metastable zone; a supersaturated solution may not nucleate for a long 
period, unless the solution is mechanically shocked or a seed crystal 
introduced. To grow well-ordered crystals of large size, the optimal 
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conditions would have to begin with the formation of a preferably single 
nucleus in the nucleation zone just beyond the metastable zone. As the 
crystals grow, the solution would return to the metastable region and no 
more nuclei could occur. The remaining nuclei would grow, at a decreasing 
rate that would help to avoid defect formation, until equilibrium is reached. 
 
 
Figure 7. Two-dimensional solubility diagram. 
 
2.13.2  Physical techniques of protein crystallization 
A number of techniques have been developed for bringing a protein solution 
into a supersaturation state. Among them, the following three methods are 
frequently used: (1) micro-batch, (2) vapour-diffusion and (3) dialysis. Although 
supersaturation of a protein solution could be achieved by means of each of these 
techniques, the underlying principles of these methods vary. 
The micro-batch method is a variation of the simple batch crystallisation 
technique, where the concentrated protein solution is mixed with concentrated 
precipitant in a closed vessel to produce a final supersaturated concentration, which 
may eventually lead to crystallisation. This can be done with large amounts of 
solutions, and typically results in larger crystals owing to the larger volumes of solute 
present and the lower chance of impurities diffusing onto the face of the crystal. In 
the micro-batch technique, smaller volumes, as little as 0.5 mL, can be used. The 
protein sample and precipitant solution are dispensed into the well of a plate and 
the well is covered with paraffin oil to prevent evaporation (figure 8a). During the 
incubation period, the concentration of a precipitant agent remains constant since 
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evaporation is limited and, therefore, the volume of the drop remains the same 
during the experiment. On the other hand, the concentration of the protein changes 
on formation of either crystals or amorphous precipitant. If the concentration of 
precipitant agent is chosen in such a way that the solution is in an undersaturated 
state, crystallisation will never occur.  
In terms of phase diagram, as shown in figure 9a, this condition is indicated 
by point A. The protein will immediately precipitate if the starting point is located in 
the precipitation zone of the solubility diagram, point C. Therefore, only those points 
in the phase diagram (point B in figure 9a) which lie between the solubility and 
precipitation curves represent starting conditions for a successful crystallisation 
experiment.  
The main disadvantage of this method is that the equilibration occurs very 
rapidly, thus affecting the rate of crystal growth and consequently the quality of the 
obtained crystals. The second disadvantage is that the manipulation of the crystals 
from the drop covered by oil is very difficult. However, since the use of very small 
volumes of protein solution can be made, the micro-batch technique is quite useful 
as an initial screening method.  Although the evaporation of water from the drop 
covered by oil is negligible, it does occur, and therefore the 'life-time' of micro-batch 
trials is usually about 2 to 3 weeks. 
 
 
Figure 8a: Protein crystallisation techniques. Schematic representation 
of microbatch  crystallisation technique. 
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Figure 9a : Various crystallisation set-ups explained in terms of phase diagrams. 
Schematic representation of solubility phase diagram and correlation between 
protein and crystallising agent concentrations in  batch crystallisation experiments. 
Cip and Ci are the initial concentrations of protein and crystallising agent 
respectively, Cfp and Cf are their final concentrations.   
 
The method of vapor diffusion is the most widely used one. There are two 
common procedures for conducting vapor diffusion crystallization: they are either 
based on a drop, which is supported by some surface, in which case it is called a 
sitting drop (figure 8b), or based on an arrangement, where the drop is suspended 
from some surface and it is called a hanging drop (figure 8b), which is also the 
technique used in this experimental work). A third approach in which the protein 
sample droplet is simultaneously in contact with both an upper and lower surface, 
called a sandwich drop (figure 8b), is sometimes used, but for special purposes only 
such as making optical measurements.  
In both vapor diffusion experiments a protein droplet containing purified 
protein, buffer and precipitant, is closed in a microwell with a reservoir of similar 
buffers and precipitants. Nevertheless their concentrations are higher than in the 
protein droplet. The reservoir does not contain the protein. At the very beginning of 
the experiment the protein and precipitant in the protein droplet are in too low of a 
concentration to cause the protein to crystallize, therefore the system is 
undersaturated. During the course of the experiment water vaporizes from the 
protein droplet and is collected in the reservoir. The decrease in water in the protein 
droplet moves the protein droplet, from a state of undersaturation to a state, where 
the protein and precipitant concentration in the protein droplet are sufficiently high, 
so that the protein crystallization occurs in the protein droplet. The net transfer of 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 10:16:14 EET - 137.108.70.7
49 
 
water from the protein droplet to the reservoir is equilibrium and that is the reason 
why optimum temperature conditions in the microwell should be maintained until 
crystallization is complete.  
During a vapour-diffusion experiment, the protein will start to concentrate 
from an unsaturated state (point A, concentration Cpi ) to reach a supersaturated 
state (point B). As the first crystals appear the concentration of protein will decrease 
(figure 9b). The crystal will then grow until the concentration of the protein in the 
drop reaches the solubility curve (point C, at concentration Cfp). 
A major advantage of the vapor diffusion technique is the possibility of 
affecting the equilibration rate and thus approaching supersaturation more slowly, 
by varying the distance between the reservoir and the crystallization drop. The 
equilibration process can also be slowed down by inserting an oil barrier over the 
reservoir. A further advantage is the ability to alter the composition and/or the 
concentration of the components in the crystallizing solution during the experiment 
without having to touch the drop. This can be achieved by either concentration or 
dilution of the reservoir. 
However, this method has some disadvantages too: once nucleation 
conditions are achieved, the solution remains highly supersaturated, so that both 
nucleation and rapid crystal growth can occur simultaneously. Moreover, during the 
experiment the conditions are changing continuously, thus leaving the investigator 
guessing at which conditions crystallization takes place. 
 
 
Figure 8b : Protein crystallisation techniques. Schematic representation of  vapour-
diffusion crystallisation technique. 
Institutional Repository - Library & Information Centre - University of Thessaly




Figure 9b: Various crystallisation set-ups explained in terms of phase diagrams. 
Schematic representation of solubility phase diagram and correlation between 
protein and crystallising agent concentrations in vapour-diffusion. Cip and Ci are the 
initial concentrations of protein and crystallising agent respectively, Cfp and Cf are 
their final concentrations. 
 
Dialysis techniques utilize diffusion and equilibration of small precipitant 
molecules through a semipermeable membrane as a means of slowly approaching 
the concentration at which the macromolecule solute crystallizes. Initially, the 
protein solution is contained within the dialysis membrane, which is then 
equilibrated against a precipitant solution. Equilibration against the precipitant in 
the surrounding solvent slowly achieves supersaturation for the solute within the 
dialysis membrane, eventually resulting in crystallization. A dialysis membrane can 
be used to cover the opening of a dialysis button, allowing diffusion of the 
surrounding solvent into the solute through the dialysis membrane (figure 8c). 
Dialysis buttons themselves come in a variety of sizes from 7 mL to 200 mL.  
The protein solution at the start of the dialysis experiment is in an 
undersaturated state (figure 9c). The concentration of the precipitant agent slowly 
increases as its diffusion through the membrane takes place. Thus, the system goes 
from an undersaturated state into the metastable region through the point S on the 
solubility curve. 
The advantage of dialysis over other methods is in the ease with which the 
precipitating solution can be varied, simply by moving the entire dialysis button or 
sack from one condition to another. Thus, the protein solution can be continuously 
recycled until the correct conditions for crystallization are found.  
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Figure 8c : Protein crystallization techniques. Schematic representation of  




Figure 9c. Various crystallization set-ups explained in terms of phase diagrams. 
Schematic representation of solubility phase diagram and correlation between 
protein and crystallizing agent concentrations in dialysis crystallization experiments. 
Cip and Ci are the initial concentrations of protein and crystallizing agent 
respectively, Cfp and Cf are their final concentrations.   
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2.13.3  Crystallisation plate preparation protocol 
 
 Technique used: hanging drop method. 
 Pre-greased LINBRO™ 24-well crystallisation plate. 
 Crystallisation mix (reservoir volume): 800 μL. 
 Crystallisation condition we have worked with – composition: 
 Ribonuclease 7, “Rosenberg” variant, 30 mg/mL in sodium cacodylate 
buffer 20mM pH5 
 Initial crystallisation mixture: (NH4)2SO4 2,4M + Bicine buffer 0,1M 
pH9 
 Reservoir mixtures are prepared, deciding which conditions and 
concentrations we will be working with i. e. We  study what varying 
crystallisation components’ concentrations (ammonium sulphate, buffer, pH 
values, etc.) may result in 
 The corresponding crystallization mixture component volume is calculated 
out of the initial stock concentration ( Vstock = Creservoir 
. Vreservoir/ Cstock). 
             Stock concentrations: (NH4)2SO4 3,5 M 
                                Different buffers (TRIS, CHES), pH values (8,5; 9; 9,5; 10) 
 Once all well’s reservoir volumes have been calculated, we pour gently each 
component amount (e.g. 80 μL buffer) into the well. A concrete addition 
order is preferred in order to avoid eventual bad mixing or precipitation 
problems. Thus, first mQ (twice distillated) water is added, then the buffer 
and finally the salt. 
 Since we will be using the hanging drop method the protein will be hanging 
from a glass coverslip (should be clean enough to avoid any dust interfering 
with the final drop + reservoir crystallization mixture drop) placed over the 
well (already filled with the reservoir mixture). In order to prepare the final 
protein+reservoir drop, we simply take 1μL of the protein sample, put it on 
the coverslip and then add 1μL of the reservoir composition (crystallisation 
condition) very gently. We avoid making any bubbles or strong mixing, as the 
protein could be damaged. To avoid eventual bad mixing or precipitation 
problems, we will start adding mQ (twice distillated) water and then go on 
with the buffer and finally salt. 
 We turn over the coverslip rapidly and put it directly over the pre greased 
well border. Once all wells have been covered, we cover the whole plate 
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1. Protein expression and purification 
The recombinant RNase 7 was expressed using Escherichia Coli BL21 cells 
transformed with vector Pet11C with insertion of RNase 7 synthetic gene. Protein is 
obtained and purified from the inclusion bodies.  
1.1 Protein production 
 Transformation into receptive cells E. Coli BL21 by the use of antibiotic Amp 
(100 μg/mL) 
 2 L culture of bacterial cells are inoculated at a temperature of 37oC under 
stirring along with the antibiotic Amp until an OD600=0.6 is reached (3h). 
 Induction in a temperature of 37oC for 4 hours with IPTG to a final 
concentration of 1 mM. 
 Aliquots before and after induction are kept to be used for SDS-PAGE 
electrophoresis. 
 Collection of cells by centrifugation (12.000 rpm for 10 min at 4oC). Then, the 
supernatant is discarded and the pellet may be used for further processing, 
or can be stored at – 20oC.  The pellet contains the inclusion bodies, which 
are insoluble aggregates. 
 
1.2 Purification  
Sonication is necessary for the purification of our recombinant protein from 
inclusion bodies. It is important that cell lysis is complete, because intact cells 
sediment together with the inclusion bodies, thus contaminating the preparation. 
 Resuspension of the pellet in 80 mL of lysis buffer to  remove as much 
bacterial protein as possible from the aggregated foreign protein and then 
sonication for the lysis of cells and centrifugation (16.000 rpm for 30 min at 
4oC). The supernatant is scattered and the pellet is kept in fridge. 
The inclusion bodies are still insoluble, so in order to obtain soluble active 
proteins from inclusion bodies denaturing and refolding steps are necessary. First, 
they are washed to remove contaminants, and then they are solubilised in 
denaturing buffer which contains a reducing agent. After centrifugation, the 
supernatant which contains the unfolded proteins is gradually incubated in refolding 
buffer to recover soluble and active proteins. 
 Resuspension of the pellet in 20 mL of  washing buffer. 
 Centrifugation for 30 minutes  at 12.000 rpm at 4 oC. 
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 Resuspension of the pellet in 25 mL of denaturing buffer, which is reduced 
with glutathion (80 mM). 
 Centrifugation in 12.000 rpm for 30 minutes and gradual incubation (5 mL / 
min) of the supernatant this time to 2 L of refolding buffer. (sample A) 
 
The final step for the purification of the recombinant RNase 7 is achieved by  
high-resolution ion-exchange chromatography. 
 DEAE – sepharose and CM – sepharose column is first equilibrated with the 
solution A with a flow of 1 mL/min. 
 Filtration of sample A so as to be condensed and prevent loading of  
misfolded proteins in the column. After filtration, it is loaded in the column. 
 The washout of columns by the same solution follows (solution A) for 5h. 
 Elution of the protein from the CM – sepharose column (which is negatively 
charged) with the use of NaCl linear gradient (solution A + NaCl). 
The results are shown in figure 1. The peaks represent proteins and the most 
characteristic peak is an indication of our protein.  
 
 
         Figure 1. Ion exchange chromatography with Resource S column using HPLC. 
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The fraction 5 shows a peak. So after centrifugation, 1mL of the protein has 
absorbance A=0.4 in 280nm. As a reference we used water. The quantity of the 
protein obtained is 38,2 mM calculated by the Beer-Lambert law, A=ebc where: 
 ε is the molar absorption coefficient with units of L mol-1 cm-1 
 b is the path length that the incident light cross expressed in cm 
 c is the concentration of the compound in solution, expressed in mol L-1 
So if we calculate the total amount of the protein (converting molecular 
concentration in mass) we purified and divided it by the total volume (in L) of the 
bacterial culture used to express this protein. Then this results in the production of 8 
mg of pure protein per liter of bacterial culture.   
 
2. SDS – polyacrylamide gel electrophoresis 
The purity of the protein fraction was checked by SDS – PAGE. From the 
results of the chromatography, we speculate that the fraction of the protein in the 
5th tube corresponds to the purified RNase 7, since it shows the highest peak. To 
assure this speculation, 20μl of this fraction are mixed with 10μl loading buffer and 
are uploaded in the gel. Samples before induction and after induction are also 
uploaded in the gel with the process which is mentioned previously (p.37). 
 As a marker, an RNase A sample (10 μL) is used which is mixed with 5 μL of 
loading buffer and is placed in the first well of the gel  (7,5 μL) 
  During the process of induction (p.25), a sample (B.I) was taken before the 
injection of IPTG from the culture and another one (A.I) after adding the 
IPTG. These samples are centrifuged for 5 min. In the pellet 20 μL TRIS/HCl 
are added and 10 μL loading buffer. A total amount of 20 μL of each sample is 
uploaded in the wells. 
 We centrifuge (10 min in 10 oC) the fraction from the chromatography, which 
is in tube 5. We put it in a special eppendorf type tubes along with water, 
which holds the protein, and discards water and salts (5 centrifugations). A 
total amount of 20 μL of the sample is uploaded in the wells.. 
All the samples were heated before the uploading in the gel. The figure 2 
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Figure 2. SDS-PAGE electrophoresis. The first band starting from the right is the marker, the second 
the sample B.I, the third the sample A.I and the last that from the chromatography (tube 5). 
As it is seen, the expression of the protein is induced after the injection of 
IPTG, since it is represented with a more intense band in the gel, compared to the 
one before induction. The last band confirms that the purified fraction from the 
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3. Ribonuclease activity by zymogram 
Zymography is used in order to determine if our protein displays enzyme 
activity. The exact process is described above (p. 40). In this case, a sample of 10μl is 
taken from fraction 5 of the ion exchange chromatography. Samples are prepared 
without boiling to preserve the structure and activity of the enzyme. 
 
 
Figure 3. Zymogram.: . The first band starting from the right is the marker and the second the sample  
from the chromatography (tube 5). 
 
As it is seen, RNase 7, which is visualized by negative staining, has digested 
the poly-U substrate, and is represented as clear band in the gel, which means that 
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4. Antibacterial activity 
To determine if RNase 8 displays antibacterial activity, the diffusion or agar 
plate method is performed, as described previously (p.42). In each plate, we 
measure the colonies by dividing it into 4 quadrants. The results are the following: 
 
1. (0,0195μM)          274x4 = 1096 
2. (0,039 μM)            283x4 = 1132 
3. (0,078 μM)            140x4 = 160 
4. (0,156 μM)            21x4 = 84 
5. (0,3125 μM)          0 
6. (0,625 μM)            0 
7. (1,25 μM)          0 
8. (2,5 μM)            0 
9. (5 μM)               0 
10. (10 μM)             0 
 
From these data, we can come to the conclusion that as the protein 
concentration increases, the bacterial growth is inhibited, until there are plates, 
where no bacterial growth is noticed. This inhibition, starts from the plate 5, which 
represents also the MIC of the protein and of course continues in the next plates, 
where the concentration of RNase 7 is even higher. So, RNase 7 justifies its 
characterization as an AMP. More specifically, its antibacterial activity is calculated 
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The experimental procedure of crystallization is described previously (p.52). 
Through the trial-and-error principle, several experiments took place took place 
under different conditions, in order to find the optimal ones for the formation of 
crystals. The table below shows the conditions for each test of the experiment: 
Plate 1: different pH values and buffers 
(NH4)2SO4 2,4M 
TRIS 0,1M pH9 
(NH4)2SO4 2,4M 
TRIS 0,1M pH9,5 
(NH4)2SO4 2,4M 
CHES 0,1M pH9,5 
(NH4)2SO4 2,4M 
CHES 0,1M pH10 
 
Results: Better results are obtained with TRIS, where there was not too much 
precipitation. So, in the next plate, we use TRIS as buffer, investigating the values. 
 














Results: Better results are obtained at the concentration of 1,85M (NH4)2SO4, where 
a procrystal structure is observed. So, in the next plate we investigate a shorter 
(NH4)2SO4 concentration range. 
 





















Results: No significant results (i.e. crystals) were obtained. Only crystal-like 
structures were observed. Therefore, more conditions should be explored to achieve 
crystal growth. 
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